Literature DB >> 24692493

High-throughput RNAi screening for germline apoptosis genes in Caenorhabditis elegans.

Benjamin Lant1, W Brent Derry.   

Abstract

Among the greatest tools that Caenorhabditis elegans can provide researchers are the capabilities to perform high-throughput, genome-wide screens. Using bacterial RNAi libraries, which cover the majority (>85%) of the worm genome, genes can be rapidly and systematically evaluated for apoptosis phenotypes in the germline. Screens can be designed to directly assess the levels of apoptotic corpses under normal physiological conditions using transgenic strains expressing fluorescent reporters that mark apoptotic bodies. Vital dyes that are selectively retained in apoptotic cells, such as acridine orange (AO), can also be used to screen for genes that regulate germline apoptosis. Using these reagents, screens can be performed in wild-type worms or mutant backgrounds that suppress or enhance apoptosis phenotypes. This protocol describes methods for designing and carrying out high-throughput or targeted RNAi screens for germline apoptosis regulators.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24692493     DOI: 10.1101/pdb.prot080234

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  1 in total

1.  Classes of Drugs that Mitigate Radiation Syndromes.

Authors:  Ewa D Micewicz; Robert D Damoiseaux; Gang Deng; Adrian Gomez; Keisuke S Iwamoto; Michael E Jung; Christine Nguyen; Andrew J Norris; Josephine A Ratikan; Piotr Ruchala; James W Sayre; Dörthe Schaue; Julian P Whitelegge; William H McBride
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.